Biology of cancer; from cellular and molecular mechanisms to developmental processes and adaptation

IG Motofei - Seminars in Cancer Biology, 2022 - Elsevier
Cancer research has been largely focused on the cellular and molecular levels of
investigation. Recent data show that not only the cell but also the extracellular matrix plays a …

Breaking the stromal barrier in pancreatic cancer: Advances and challenges

M Chakkera, JB Foote, B Farran… - Biochimica et Biophysica …, 2024 - Elsevier
Pancreatic cancer (PC) remains a leading cause of mortality worldwide due to the absence
of early detection methods and the low success rates of traditional therapeutic strategies …

Identification of prognostic genes in the pancreatic adenocarcinoma immune microenvironment by integrated bioinformatics analysis

H Wang, L Lu, X Liang, Y Chen - Cancer Immunology, Immunotherapy, 2022 - Springer
Purpose Pancreatic adenocarcinoma (PAAD) is one of the most common causes of death
among solid tumors, and its pathogenesis remains to be clarified. This study aims to …

A functional outside-in signaling network of proteoglycans and matrix molecules regulating autophagy

T Neill, A Kapoor, C Xie, S Buraschi, RV Iozzo - Matrix Biology, 2021 - Elsevier
Proteoglycans and selected extracellular matrix constituents are emerging as intrinsic and
critical regulators of evolutionarily conversed, intracellular catabolic pathways. Often, these …

Upregulated Matrisomal Proteins and Extracellular Matrix Mechanosignaling Underlie Obesity-Associated Promotion of Pancreatic Ductal Adenocarcinoma

RT Waldron, A Lugea, HH Chang, HY Su, C Quiros… - Cancers, 2024 - mdpi.com
Simple Summary Epidemiologic evidence and previous research have established obesity,
diabetes and the metabolic syndrome as risk factors for pancreatic cancer in humans, while …

[HTML][HTML] Extracellular matrix gene expression signatures as cell type and cell state identifiers

F Sacher, C Feregrino, P Tschopp, CY Ewald - Matrix Biology Plus, 2021 - Elsevier
Transcriptomic signatures based on cellular mRNA expression profiles can be used to
categorize cell types and states. Yet whether different functional groups of genes perform …

[HTML][HTML] Bromodomain and extra-terminal inhibitors emerge as potential therapeutic avenues for gastrointestinal cancers

HY Sun, ST Du, YY Li, GT Deng… - World journal of …, 2022 - ncbi.nlm.nih.gov
Gastrointestinal (GI) cancers, including colorectal cancer, pancreatic cancer, liver cancer
and gastric cancer, are severe social burdens due to high incidence and mortality rates …

Heterogeneity in pancreatic cancer fibroblasts—tgfβ as a master regulator?

DM Watt, JP Morton - Cancers, 2021 - mdpi.com
Simple Summary Pancreatic cancer has a very low survival rate and improved treatments
are required. In addition to tumour cells, the disease is characterized by a significant non …

Molecular profiling and specific targeting of gemcitabine-resistant subclones in heterogeneous pancreatic cancer cell populations

B Färber, O Lapshyna, A Künstner, M Kohl… - Frontiers in …, 2023 - frontiersin.org
Purpose Chemotherapy is pivotal in the multimodal treatment of pancreatic ductal
adenocarcinoma (PDAC). Technical advances unveiled a high degree of inter-and …

Analysis of pancreatic extracellular matrix protein post-translational modifications via electrostatic repulsion-hydrophilic interaction chromatography coupled with mass …

DN Tabang, Y Cui, DM Tremmel, M Ford, Z Li… - Molecular omics, 2021 - pubs.rsc.org
The pancreas is a vital organ with digestive and endocrine roles, and diseases of the
pancreas affect millions of people yearly. A better understanding of the pancreas proteome …